Financial Results
Consolidated Income Statement Data
| (Thousands of euro) | 1Q 2024 | 1Q 2023 |
| Revenue | 28,994 | 28,460 |
| Gross profit % on sales | 11,735 40.5% | 12,570 44.2% |
| Operating profit (loss) % on sales | (26,641) -91.9% | (3,041) -10.7% |
| EBITDA % on sales | (24,065) -83.0% | (518) -1.8% |
| Income before taxes % on sales | (19,312) -66.6% | (1,558) -5.5% |
| Profit (loss) from discontinued operations, net of taxes % on sales | 0 0.0% | 6,833 24.0% |
| Group net income (loss) % on sales | (14,819) -51.1% | 5,166 18.2% |
Consolidated Balance Sheet Data
| (Thousands of euro) | March 31, 2024 | December 31, 2023 |
| Group shareholders’ equity | 809,552 | 823,190 |
| Net financial position | 754,624 | 773,334 |
Growing revenue, mainly driven by the chemicals and high vacuum divisions
Results penalized by non-recurring costs of €23.9 million
- Consolidated revenue equal to €29 million, up by 1.9% compared to €28.5 million in 1Q 2023 despite the penalizing exchange rate effect
- Consolidated gross profit equal to €11.7 million (40.5% of revenue) in 1Q 2024, compared to €12.6 million (44.2% of revenue) in 1Q 2023
- Consolidated operating profit negative and equal to -€26.6 million in 1Q 2024, of which non-recurring costs amounted to €23.9 million
- Consolidated EBITDA negative and equal to -€24.1 million in 1Q 2024, again penalized by non-recurring costs (€23.9 million)
- Positive financial management of €8 million in 1Q 2024
- Consolidated result negative and equal to -€14.8 million
- Positive consolidated net financial position of €754.6 million as at March 31, 2024